SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steeny who wrote (732)3/3/2000 7:51:00 AM
From: david james  Read Replies (1) of 1298
 
A good source for information on Cell Genesys
biospace.com

with a bit more data here
biospace.com

It is interesting to consider that just the interest on that $250 mill in cash will be $15 mill at 6% - or 50 cents a share in earnings.

With their current revenue streams and the $45 mill coming in from Japanese Tobacco, it is likely CEGE will profitable this year (not that it is much of a factor considering they involved in the cure for cancer).

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext